Trial Profile

Protection against nephropathy in diabetes with atorvastatin

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 29 Jan 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Atorvastatin (Primary)
Indications Diabetic nephropathies; Proteinuria
Focus Pharmacodynamics; Therapeutic Use
Acronyms PANDA

Most Recent Events

19 Mar 2014 Accrual to date is 98% according to United Kingdom Clinical Research Network record.
17 Aug 2013 Accrual to date is 98% according to United Kingdom Clinical Research Network record.
15 Mar 2011 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com